טוען...
Simultaneous use of erythropoietin and LFM‐A13 as a new therapeutic approach for colorectal cancer
BACKGROUND AND PURPOSE: Bruton's tyrosine kinase (Btk) is a non‐receptor tyrosine kinase involved in the activation of signalling pathways responsible for cell maturation and viability. Btk has previously been reported to be overexpressed in colon cancers. This kind of cancer is often accompani...
שמור ב:
| הוצא לאור ב: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811618/ https://ncbi.nlm.nih.gov/pubmed/29160911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14099 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|